Painengda

Painengda is a Traditional Chinese Medicine (TCM) preparation, typically administered as a capsule, developed for the treatment of immune thrombocytopenia (ITP). It is specifically indicated for patients presenting with 'Qi and Blood deficiency syndrome' according to TCM diagnostic principles. The drug has been evaluated in Phase II clinical trials, such as those sponsored by the Zhejiang Provincial Hospital of Traditional Chinese Medicine, to assess its efficacy in increasing platelet counts and its safety profile. As a botanical formulation, its therapeutic effect is likely derived from multi-target immunomodulation and support of hematopoiesis, although specific molecular targets are not typically defined in standard pharmacological terms.

Brand names

Painengda

Other names

Painengda Capsule派能达